Company / Net Income
Yubo International Biotech Ltd Net Income History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$1.1M
FY2025
5-year range
-$1.8M / -$711.8K
FY2021-FY2025
Trend
+39.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has fluctuated over the past 10 years, ranging from -$2M in FY2024 to -$130,000 in FY2015.
Based on SEC 10-K filings.
-$1M in FY2025.
Improved from -$1M to -$1M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 39.2% year-over-year.
- Peak net income was recorded in FY2015.
- Lowest net income in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.1M | +39.2% |
| FY2024 | -$1.8M | -48.6% |
| FY2023 | -$1.2M | +0.8% |
| FY2022 | -$1.2M | -69.3% |
| FY2020 | -$711.8K | -380.9% |
| FY2019 | -$148.0K | -2.8% |
| FY2018 | -$144.0K | +0.0% |
| FY2017 | -$144.0K | +35.7% |
| FY2016 | -$224.0K | -72.3% |
| FY2015 | -$130.0K | -54.8% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026